title: Riluzole and olanzapine in Huntington's disease.
authors.forename: Raphael M
authors.initials: RM
authors.lastname: Bonelli
authors.forename: G
authors.initials: G
authors.lastname: Niederwieser
authors.forename: J
authors.initials: J
authors.lastname: Diez
authors.forename: P
authors.initials: P
authors.lastname: Költringer
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage*; D001569:Benzodiazepines; D005260:Female; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy*; D008297:Male; D018696:Neuroprotective Agents / Q000008:administration & dosage*; D000077152:Olanzapine; D010890:Pirenzepine / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D019782:Riluzole / Q000008:administration & dosage*
chemical_list: D014150:Antipsychotic Agents; D018696:Neuroprotective Agents; D001569:Benzodiazepines; D010890:Pirenzepine; D019782:Riluzole; D000077152:Olanzapine